Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 101.64

-2.2%

3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sam who wrote (743)	10/15/1998 2:44:00 PM
From: Rocketman	Read Replies (1) of 3202

Gee I guess it is a big surprise that they were going to expense the Hexagen purchase and that Hexagen is a money loser for now - if you ignore what the company has been saying. What a surprise - NOT! The Incyte General division hit the expected EPS of 20 cents right on the money before you figure in Hexagen. The markets are basically into punishing companies for building for the long term. It is totally a what have you done for me this quarter mentality. Thus, some analysts have to react, after the fact of course - what superior powers of anticipation they have. And, since some analysts react, then some shareholders have to pull the trigger and dump an excessive number of shares and tank the price. Makes for a great buying opportunity though. Back up the truck is my advice. Rman

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next